Assay Development Automation Drug Discovery Proteomics

Dianthus New Product Icon 

NanoTemper Technologies, Inc

Booth: 006

Researchers in Pharma and CROs face the challenges that drug candidates and targets like PROTACs, intrinsically disordered proteins, and fragment libraries present when it comes to affinity-based screening. The new Dianthus is a plate-based and microfluidics-free affinity-based screening platform that will offer researchers their best chance to be successful faster at these challenging screening. Dianthus wins in these applications by offering two biophysical modalities — spectral shift and TRIC — so you:

• Get results faster with less assay development
• Easily decide with confidence which hits to move forward with thanks to high-quality data
• Count on a biophysical method with the sensitivity you need to identify all the meaningful hits
• Secure results even from your less-than-perfect samples —impure, impacted by freeze and thaw cycles, or with precipitate or aggregates

Make sure to sign up to learn when the new Dianthus launches.






Request Information





 
By requesting information, you agree to share the email you provided at the time of registration with the exhibitor for follow-up. Click on “Submit” to share your email or “Cancel” to cancel your information request.
 
 
Comments